Reply to R. Pham et al

JCO Precis Oncol. 2022 Mar:6:e2200053. doi: 10.1200/PO.22.00053.

Authors

Iris van 't Erve¹, Cornelis J A Punt¹, Gerrit A Meijer¹, Remond J A Fijneman¹

Affiliation

¹ Iris van 't Erve, MSc, Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Cornelis J.A. Punt, MD, PhD, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; and Gerrit A. Meijer, MD, PhD, and Remond J.A. Fijneman, PhD, Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

PMID: 35344447
DOI: 10.1200/PO.22.00053

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment